Aadi Bioscience, Inc. (AADI) Financials
AADI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 132.4 million | 27.2 million |
2023-09-30 | 139.7 million | 21.5 million |
2023-06-30 | 151.2 million | 19.8 million |
2023-03-31 | 170.7 million | 24.7 million |
AADI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -10.5 million | 3.1 million |
2023-09-30 | -13.0 million | 3.0 million |
2023-06-30 | -17.4 million | 3.1 million |
2023-03-31 | -22.7 million | 2.7 million |
AADI Net Income
No data available :(
AADI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 108.8 million | - | 1.3 million |
2023-09-30 | 119.3 million | - | 1.4 million |
2023-06-30 | 134.9 million | - | 1.5 million |
2023-03-31 | 151.2 million | - | 1.6 million |
AADI Shares Outstanding
AADI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 816000 | 12.8 million | 10.3 million | - |
2023-09-30 | 1.1 million | 11.9 million | 11.2 million | - |
2023-06-30 | 689000 | 13.3 million | 11.8 million | - |
2023-03-31 | 1.4 million | 11.0 million | 11.2 million | - |
AADI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 6.3 million | 927000 |
2023-09-30 | 6.0 million | 697000 |
2023-06-30 | 6.2 million | 656000 |
2023-03-31 | 5.9 million | 529000 |
AADI
Price: $2.12
52 week price:
Earnings Per Share: -2.44 USD
P/E Ratio: -0.82
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 52100
Market Capitalization: 46.7 million